{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:23:21Z","timestamp":1793316201544,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00467-020-04664-7","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T01:13:22Z","timestamp":1593479602000},"page":"2345-2352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical evaluation of the Prismaflex\u2122 HF 20 set and Prismaflex\u2122 system 7.10 for acute continuous kidney replacement therapy (CKRT) in children"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3715-1692","authenticated-orcid":false,"given":"Raj","family":"Munshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Lee-Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Hackbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Echeverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"4664_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s004670000420","volume":"15","author":"BA Warady","year":"2000","unstructured":"Warady BA, Bunchman T (2000) Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 15:11\u201313","journal-title":"Pediatr Nephrol"},{"key":"4664_CR2","doi-asserted-by":"publisher","unstructured":"Sethi SK, Chakraborty R, Joshi H, Raina R (2020) Renal replacement therapy in pediatric acute kidney injury. Indian J Pediatr. https:\/\/doi.org\/10.1007\/s12098-019-03150-9","DOI":"10.1007\/s12098-019-03150-9"},{"key":"4664_CR3","unstructured":"Available from: www.baxter.com"},{"key":"4664_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0272-6386(03)00195-1","volume":"41","author":"JM Symons","year":"2003","unstructured":"Symons JM, Brophy PD, Gregory MJ, McAfee N, Somers MJG, Bunchman TE, Goldstein SL (2003) Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 41:984\u2013989","journal-title":"Am J Kidney Dis"},{"key":"4664_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2215\/CJN.03200906","volume":"2","author":"JM Symons","year":"2007","unstructured":"Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2:732\u2013738","journal-title":"Clin J Am Soc Nephrol"},{"key":"4664_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1053\/ajkd.2001.25212","volume":"38","author":"PD Brophy","year":"2001","unstructured":"Brophy PD, Mottes TA, Kudelka TL, McBryde KD, Gardner JJ, Maxvold NJ, Bunchman TE (2001) AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis 38:173\u2013178","journal-title":"Am J Kidney Dis"},{"key":"4664_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2471\/BLT.10.080010","volume":"89","author":"SR Howie","year":"2011","unstructured":"Howie SR (2011) Blood sample volumes in child health research: review of safe limits. Bull World Health Organ 89:46\u201353","journal-title":"Bull World Health Organ"},{"key":"4664_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12882-015-0016-6","volume":"16","author":"RK Basu","year":"2015","unstructured":"Basu RK, Kaddourah A, Terrell T, Mottes T, Arnold P, Jacobs J, Andringa J, Goldstein SL, Prospective Pediatric AKI Research Group (ppAKI) (2015) Assessment of worldwide acute kidney injury, renal angina and epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol 16:24","journal-title":"BMC Nephrol"},{"key":"4664_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00467-007-0672-2","volume":"23","author":"FX Flores","year":"2008","unstructured":"Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN, Alexander SR, Mahan JD, Bunchman TE, Blowey D, Somers MJG, Baum M, Hackbarth R, Chand D, McBryde K, Benfield M, Goldstein SL (2008) Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT registry group. Pediatr Nephrol 23:625\u2013630","journal-title":"Pediatr Nephrol"},{"key":"4664_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jpeds.2012.08.044","volume":"162","author":"DJ Askenazi","year":"2013","unstructured":"Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ (2013) Continuous renal replacement therapy for children \u226410 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 162:587\u201392.e3","journal-title":"J Pediatr"},{"key":"4664_CR11","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00467-013-2594-5","volume":"29","author":"SM Sutherland","year":"2014","unstructured":"Sutherland SM, Goldstein SL, Alexander SR (2014) The prospective pediatric continuous renal replacement therapy (ppCRRT) registry: a critical appraisal. Pediatr Nephrol 29:2069\u20132076","journal-title":"Pediatr Nephrol"},{"key":"4664_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/039139880402700104","volume":"27","author":"SL Goldstein","year":"2004","unstructured":"Goldstein SL, Somers MJ, Brophy PD, Bunchman TE, Baum M, Blowey D, Mahan JD, Flores FX, Fortenberry JD, Chua A, Alexander SR, Hackbarth R, Symons JM (2004) The prospective pediatric continuous renal replacement therapy (ppCRRT) registry: design, development and data assessed. Int J Artif Organs 27:9\u201314","journal-title":"Int J Artif Organs"},{"key":"4664_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.01900214","volume":"10","author":"SM Sutherland","year":"2015","unstructured":"Sutherland SM, Byrnes JJ, Kothari M, Longhurst CA, Dutta S, Garcia P, Goldstein SL (2015) AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol 10:554\u2013561","journal-title":"Clin J Am Soc Nephrol"},{"key":"4664_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/j.ajkd.2009.10.048","volume":"55","author":"SM Sutherland","year":"2010","unstructured":"Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJ, Baum M, Symons JM, Flores FX, Benfield M, Askenazi D, Chand D, Fortenberry JD, Mahan JD, McBryde K, Blowey D, Goldstein SL (2010) Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 55:316\u2013325","journal-title":"Am J Kidney Dis"},{"key":"4664_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20:109\u2013117","journal-title":"Drug Saf"},{"key":"4664_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/MAT.0b013e31822d2132","volume":"57","author":"S R\u00f6dl","year":"2011","unstructured":"R\u00f6dl S, Marschitz I, Mache CJ, Koestenberger M, Madler G, Zobel G (2011) Continuous renal replacement therapy with Prismaflex HF20 disposable set in children from 4 to 15 kg. ASAIO J 57:451\u2013455","journal-title":"ASAIO J"},{"key":"4664_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4067\/S0370-41062018000100074","volume":"89","author":"F Cavagnaro Santa Mar\u00eda","year":"2018","unstructured":"Cavagnaro Santa Mar\u00eda F, Roque Espinosa J, Guerra Hern\u00e1ndez P (2018) Continuous venovenous hemofiltration in neonates with hyperammonemia. A case series. Rev Chil Pediatr 89:74\u201378","journal-title":"Rev Chil Pediatr"},{"key":"4664_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00467-012-2394-3","volume":"28","author":"ID Liu","year":"2013","unstructured":"Liu ID, Ng KH, Lau PY, Yeo WS, Koh PL, Yap HK (2013) Use of HF20 membrane in critically ill unstable low-body-weight infants on inotropic support. Pediatr Nephrol 28:819\u2013822","journal-title":"Pediatr Nephrol"},{"key":"4664_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1525-1594.2011.01367.x","volume":"35","author":"MJ Santiago","year":"2011","unstructured":"Santiago MJ, L\u00f3pez-Herce J (2011) Prismaflex HF20 for continuous renal replacement therapy in critically ill children. Artif Organs 35:1194","journal-title":"Artif Organs"},{"key":"4664_CR20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2215\/CJN.01430406","volume":"1","author":"KD Liu","year":"2006","unstructured":"Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM (2006) Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 1:915\u2013919","journal-title":"Clin J Am Soc Nephrol"},{"key":"4664_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMoa0802639","volume":"359","author":"PM Palevsky","year":"2008","unstructured":"VA\/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7\u201320","journal-title":"N Engl J Med"},{"key":"4664_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000477609","volume":"42","author":"M Miklaszewska","year":"2017","unstructured":"Miklaszewska M, Korohoda P, Zachwieja K, Kobylarz K, Stefanidis CJ, Sobczak A, Dro\u017cd\u017c D (2017) Filter size not the anticoagulation method is the decisive factor in continuous renal replacement therapy circuit survival. Kidney Blood Press Res 42:327\u2013337","journal-title":"Kidney Blood Press Res"},{"key":"4664_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00467-019-04213-x","volume":"35","author":"L de Galasso","year":"2020","unstructured":"de Galasso L, Picca S, Guzzo I (2020) Dialysis modalities for the management of pediatric acute kidney injury. Pediatr Nephrol 35:753\u2013765","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04664-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T19:40:48Z","timestamp":1624995648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4664"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04664-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"5 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Stuart L. Goldstein: Baxter Healthcare provided funding for the current study. Dr. Goldstein receives other grant funding, consultancy fees and is on the Expert Speaker panel for Baxter Healthcare. None of these activities were related to the current study. Scott M. Sutherland: Expert Speaker panel for Baxter Healthcare. None of these activities were related to the current study. Jorge Echeverri: Global Medical Director, Acute Therapies for Baxter Healthcare Corporation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}